FDA Investigator Cynthia L Rakestraw

Cynthia L Rakestraw has conducted inspections on 411 sites in 14 countries as of 12 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
411
Last Inspection Date:
12 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100006413
Countries of Inspections:
United States of America, Japan, Germany, Australia, Canada, Belgium, Argentina, Italy, United Kingdom of Great Britain and Northern Ireland, Spain, Serbia, Hungary, Finland, Poland
FDA Investigators that have inspected at least one site in common with Cynthia L Rakestraw:
Amanda B Athey, Amanda B Vega, Andria L Kuhlman, Barbara M Frazier, Benjamin J Dastoli, Brandon L Mariner, Brandon M Kurjanowicz, Brittany M Kershaw, Carl E Lovrich, Christina K Theodorou, Craig T Rybus, Crayton Lee, Cynthia A Harris, MD, RN, Cynthia F Kleppinger, MD, Cythia L Rakestraw, Daniel J Mechenbier, Daniel R Tammariello, Dauksism, Dennis R Hock, Dr. Mark J Seaton, PhD, Elizabeth B Griffin, Erica L Nicoll, Erika M Wilkerson, Erin L Mcfiren, Francis A Guidry, Gayle S Lawson, Geoffrey K Kilili, Gerald N Mcgirl, DDS, Gladys B Casper, Gregory E Beichner, Hasan A Irier, PhD, Hugh M Mcclure, II, James M Kewley, James M Odonnell, James P Duggan, James W Leonette, Janet L Bowen, Jennifer L Jager, Jennifer L Sheehan, John B Crowe, Joseph A Dinardo, Joseph L Despins, PhD, Joseph R Hatcher, Julie Scoma, Karen A Spencer, Karen M Cooper, Karen M Kondas, Karen S Anthony, Katelyn Astaub Zamperini, Kathryn Suttling, Khin Mang U, MD, Kimberly A Dux, Kirk A Dymbrowski, LCDR Margaret Edi Gennaro, LCDR Susan E Polifko, LCDR William H Bender, Leslie W Rhodes, DVM, Lisa B Orr, LTJG Bradley E Benasutti, Margaret M Annes, Marjorie L Davis, Marlene L Davis, Mary E Storch, Mary R Kirker, Michael J Diskin, Michael L Casner, Michael R Klapal, Paula J Bretz, Richard W Berning, Ruark Lanham, Sandra L Shire, DMD, MPA, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen J Kilker, Stephen J Rabe, Susan D Yuscius, Tammy M Phillips, Teena H Aiken, Theressa B Smith, Thomas E Friel, Tiffani D Wilson, Travis R Hunt, Van Cliff, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, William A Warnick, Xiaohan Cai, PhD, Yvette Mlacour Davis

Cynthia L Rakestraw's Documents

Publish Date Document Type Title
March, 2004 EIR Mark H. Wholey, M.D. - EIR, 2004-03-23
May, 2003 EIR Mahmood Usman, MD - EIR, 2003-05-13
March, 2004 FDA 483 Response Mark H. Wholey, M.D. - Form 483R, 2004-04-06
February, 2016 EIR Bernard H. Doft, M.D. - EIR, 2016-02-25
January, 2016 FDA 483 William C. Christie, MD - Form 483, 2016-01-14
January, 2020 FDA 483 Gerard (nmi) Vockley, MD, PhD - Form 483, 2020-01-29
February, 2014 FDA 483 Castle Cheese, Inc. - Form 483, 2014-02-13
September, 2014 FDA 483 Hieber's Pharmacy - Form 483, 2014-09-18
May, 2007 FDA 483 Chatta, Gurkamal M.D. - Form 483, 2007-05-30
April, 2018 FDA 483 Abraham S. Kanate, MD - Form 483, 2018-04-13
February, 2016 FDA 483 Response Bernard H. Doft, M.D. - Form 483R, 2016-03-03
March, 2004 FDA 483 Mark H. Wholey, M.D. - Form 483, 2004-03-23
March, 2007 EIR Gustav R. Eles, DO - EIR, 2007-03-27
August, 2017 FDA 483 Ashutosh P. Jadhav, MD, PhD - Form 483, 2017-08-11
December, 2012 FDA 483 James F. Pingpank, Jr., MD - Form 483, 2012-12-06
August, 2018 FDA 483 Anne M. Zomcik MD - Form 483, 2018-08-03
February, 2022 FDA 483 Frank C. Sciurba, M.D. - Form 483, 2022-02-22
December, 2004 FDA 483 Joseph S. Sanfilippo, MD - Form 483, 2004-12-21
June, 2003 FDA 483 Shelly Kafka, MD - Form 483, 2003-06-04
February, 2016 FDA 483 Bernard H. Doft, M.D. - Form 483, 2016-02-25
December, 2012 EIR James F. Pingpank, Jr., MD - EIR, 2012-12-06
April, 2004 FDA 483 Response Mark H. Wholey, M.D. - Form 483R, 2004-04-12
March, 2015 FDA 483 Gerard (nmi) Vockley, MD, PhD - Form 483, 2015-03-03
May, 2003 FDA 483 Mahmood Usman, MD - Form 483, 2003-05-13
April, 2004 FDA 483 Mark H. Wholey, M.D. - Form 483, 2004-04-01
July, 2021 FDA 483 Fernanda P. Silveira, M.D. - Form 483, 2021-07-01
January, 2016 EIR William C. Christie, MD - EIR, 2016-01-14
September, 2014 FDA 483 Response Hieber's Pharmacy - Form 483R, 2015-02-24
April, 2013 FDA 483 Dennis J. Hurwitz, M.D. - Form 483, 2013-04-02
December, 2020 FDA 483 Alison R. Sehgal, MD - Form 483, 2020-12-29
May, 2018 FDA 483 Dale E. S. King, MD - Form 483, 2018-05-11
February, 2014 EIR Castle Cheese, Inc. - EIR, 2014-02-13
February, 2015 EIR Alejandro (NMI) Hoberman, M.D. - EIR, 2015-02-04
October, 2022 FDA 483 Brian S. Burks, DVM - Form 483, 2022-10-20
October, 2018 FDA 483 Jing Zhou Hou, MD, PhD - Form 483, 2018-10-12
June, 2021 FDA 483 Leonard Appleman, M.D, PhD - Form 483, 2021-06-14
September, 2023 FDA 483 Timothy F. Burns, MD, PhD - Form 483, 2023-09-07
April, 2004 EIR Mark H. Wholey, M.D. - EIR, 2004-04-01
August, 2003 FDA 483 Magee-Womens Hospital IRB - Form 483, 2003-08-25
March, 2019 FDA 483 LifeBridge Health, Inc. IRB - Form 483, 2019-03-13
July, 2007 FDA 483 Alejandro (NMI) Hoberman, M.D. - Form 483, 2007-07-10
July, 2017 FDA 483 Sohail M. Khan, M.D. - Form 483, 2017-07-14
February, 2020 FDA 483 Ahmad (nmi) Shabsigh, MD - Form 483, 2020-02-26
April, 2021 FDA 483 Chester V. Oddis, MD - Form 483, 2021-04-29
August, 2003 EIR Magee-Womens Hospital IRB - EIR, 2003-08-25
June, 2003 EIR Shelly Kafka, MD - EIR, 2003-06-04
April, 2022 FDA 483 Wheeling Hospital IRB - Form 483, 2022-04-12
July, 2017 EIR Sohail M. Khan, M.D. - EIR, 2017-07-14
April, 2009 FDA 483 Response John M. Kirkwood, MD - Form 483R, 2009-05-01
June, 2006 EIR Amit N. Patel, MD - EIR, 2006-06-29
September, 2022 FDA 483 Angela M. Stupi, M.D. - Form 483, 2022-09-29
November, 2018 EIR Mylan Pharmaceuticals Inc. - EIR, 2018-11-07
June, 2024 FDA 483 Alejandro (NMI) Hoberman, M.D. - Form 483, 2024-06-18
October, 2023 FDA 483 Diwakar Davar, M.D. - Form 483, 2023-10-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more